Log in to save to my catalogue

Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib...

Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_468521

Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab

About this item

Full title

Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Oncology, 2017-07, Vol.93 (1), p.51-61

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Objective: The aim of this study was to investigate the correlation between human epidermal growth factor receptor 2 (HER2)-related biomarkers and the treatment outcomes using lapatinib plus capecitabine (LC) and to evaluate the influence of the estrogen receptor (ER) status in trastuzumab-refractory HER2-positive advanced breast cancer. Method: Ei...

Alternative Titles

Full title

Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_karger_primary_468521

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_468521

Other Identifiers

ISSN

0030-2414

E-ISSN

1423-0232

DOI

10.1159/000468521

How to access this item